Critical Path Institute

Critical Path Institute

Critical Path Institute is a nonprofit organization created to improve the drug development process; its consortia include more than 1,600 scientists from government regulatory and research agencies, academia, patient organizations, and bio-pharmaceutical companies. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Critical Path Institute, United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

59%


Total
Publications

793


Total Open
Publications

465


Total
Citations

30K


Open Access
Percentage

59%


Total
Publications

793


Total Open
Publications

465


Total
Citations

30K

Wikipedia

Website

download

Breakdown

20% 31% 5% 44%

Publisher Open

20%

Both

31%

Other Platform Open

5%

Closed

44%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

180

Hybrid 30%

118

No Guarantees 24%

92

Other Platform Open

Domain 84%

236

Institution 28%

78

Other Internet 21%

58

Public 1%

4

Preprint 0%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
238
DOI
Other Internet
32
Unknown Repository
Other Internet
30
Europe PMC
Domain
19
DANS - Data Archiving and Networked Services
Institution
17
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
11
University of Cambridge - Apollo
Institution
10
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
10
Elsevier - Scopus
Institution
10
The University of Arizona - UA Campus Repository
Institution
7
1 / 7

Data updated 18 August 2025

Share

Share

Share